Literature DB >> 11355260

Off-pump coronary artery bypass for a heparin-allergic patient.

H Ide1, T Fujiki, M Sato, H Endo, K Imamura, K Sudo.   

Abstract

A 46-year-old man with no history of drug allergy developed acute myocardial infarction. Coronary angiographic findings revealed triple vessel disease. Serum hepatic enzymes were elevated due to heparin administered to control infarction, and an allergic reaction developed exclusively due to heparin. To avoid heparin use, we adopted heparin-free off-pump coronary artery bypass grafting through median sternotomy. The systemic anticoagulant agent argatroban was administered to maintain active clotting time over 200 seconds. The left internal thoracic artery was anastomosed to the left anterior descending artery, the radial artery to the diagonal branch, and the right gastroepiploic artery to the right coronary artery. Patency was confirmed by postoperative coronary angiography. No complications were noted. For patients with heparin allergy, off-pump coronary artery bypass grafting is a useful maneuver, because it can be conducted using anticoagulant agents other than heparin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11355260     DOI: 10.1007/bf02913525

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  8 in total

1.  [Argatroban, a selective thrombin inhibitor, for anticoagulant therapy during and following vascular surgery].

Authors:  H Fuji; N Kurasako; T Takebayashi; T Tanaka; S Sakano; Y Kosogabe; M Mano; H Nagase
Journal:  Masui       Date:  1996-10

2.  Coronary artery bypass grafting without cardiopulmonary bypass.

Authors:  E Buffolo; C S de Andrade; J N Branco; C A Teles; L F Aguiar; W J Gomes
Journal:  Ann Thorac Surg       Date:  1996-01       Impact factor: 4.330

3.  [Evaluation of a synthetic thrombin inhibitor MD 805 as an anticoagulant after open heart and vascular surgery].

Authors:  H Sugawara; K Kumon; K Tanaka; Y Ego; Y Naito; T Fujita
Journal:  Kyobu Geka       Date:  1983

4.  Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. The importance of stereo-structure of its hydrophobic carboxamide portion.

Authors:  S Okamoto; A Hijikata; R Kikumoto; S Tonomura; H Hara; K Ninomiya; A Maruyama; M Sugano; Y Tamao
Journal:  Biochem Biophys Res Commun       Date:  1981-07-30       Impact factor: 3.575

5.  Off-pump revascularization of the circumflex artery: technical aspect and short-term results.

Authors:  R Cartier; R Blain
Journal:  Ann Thorac Surg       Date:  1999-07       Impact factor: 4.330

6.  Seven-year follow-up of coronary artery bypasses performed with and without cardiopulmonary bypass.

Authors:  S R Gundry; M A Romano; O H Shattuck; A J Razzouk; L L Bailey
Journal:  J Thorac Cardiovasc Surg       Date:  1998-06       Impact factor: 5.209

Review 7.  Clinical efficacy of heparin fractions: issues and answers.

Authors:  H L Messmore
Journal:  Crit Rev Clin Lab Sci       Date:  1986       Impact factor: 6.250

8.  Coronary artery bypass without cardiopulmonary bypass.

Authors:  A J Pfister; M S Zaki; J M Garcia; L A Mispireta; P J Corso; A G Qazi; S W Boyce; T R Coughlin; P Gurny
Journal:  Ann Thorac Surg       Date:  1992-12       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.